1Baudouin SV.The pulmonary physician in critical car 3:Critical care management of community acquired pneumonial[J].Thorax,2002,57:267-271.
2Fine MJ, Auble TE,Yearly DM,et al.A prediction rule to identify lowrisk patients with community-acquired pneumonia[J].N Engl J Med,1997,336:243-250.
3Iakovlev VP,Polushkina NR.Moxiflocaxin-antimicrobial activity and pharmacokinetic properties[J].Antibiot Khimioter,2002,47(5):19-29.
4Behra-Miellet J,Dubreuil L,Jumas-Bilak E.Antanaerobic activity of moxifloxacin compared with that of ofloxacin, ciproflocaxin, clidamycin, metronidazole and beta-lactams[J].Int J Antimicrob Agents,2002,20(5):366-374.
